BDBM50003055 CHEMBL414947::Tyr-Pro-Ser-Lys-Pro-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr

SMILES: CCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N(C)[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O

InChI Key: InChIKey=NPACAWUVVMTQHW-KGMJBNTPSA-N

Data: 2 Kd

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50003055   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Neuropeptide Y receptor type 2 (Homo sapiens (Human))	BDBM50003055 (CHEMBL414947 | Tyr-Pro-Ser-Lys-Pro-Ala-Leu-Arg-His...) Show SMILES CCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N(C)[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C110H174N34O26/c1-11-21-73(131-90(153)60(8)127-100(163)82-26-20-47-144(82)107(170)74(22-14-15-42-111)132-98(161)80(55-145)138-101(164)83-27-19-46-143(83)105(168)69(112)49-62-28-34-66(147)35-29-62)106(169)142(10)81(25-18-45-125-110(120)121)99(162)136-78(52-65-54-122-56-126-65)94(157)135-77(51-64-32-38-68(149)39-33-64)97(160)139-86(58(6)12-2)102(165)137-79(53-85(114)151)95(158)134-76(48-57(4)5)96(159)140-87(59(7)13-3)103(166)141-88(61(9)146)104(167)130-71(24-17-44-124-109(118)119)91(154)129-72(40-41-84(113)150)93(156)128-70(23-16-43-123-108(116)117)92(155)133-75(89(115)152)50-63-30-36-67(148)37-31-63/h28-39,54,56-61,69-83,86-88,145-149H,11-27,40-53,55,111-112H2,1-10H3,(H2,113,150)(H2,114,151)(H2,115,152)(H,122,126)(H,127,163)(H,128,156)(H,129,154)(H,130,167)(H,131,153)(H,132,161)(H,133,155)(H,134,158)(H,135,157)(H,136,162)(H,137,165)(H,138,164)(H,139,160)(H,140,159)(H,141,166)(H4,116,117,123)(H4,118,119,124)(H4,120,121,125)/t58-,59-,60-,61+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,86-,87-,88-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a
Salk Institute Curated by ChEMBL					Assay Description Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells				J Med Chem 35: 3653-9 (1992) BindingDB Entry DOI: 10.7270/Q2QZ2BK9
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 1 (Homo sapiens (Human))	BDBM50003055 (CHEMBL414947 | Tyr-Pro-Ser-Lys-Pro-Ala-Leu-Arg-His...) Show SMILES CCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N(C)[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C110H174N34O26/c1-11-21-73(131-90(153)60(8)127-100(163)82-26-20-47-144(82)107(170)74(22-14-15-42-111)132-98(161)80(55-145)138-101(164)83-27-19-46-143(83)105(168)69(112)49-62-28-34-66(147)35-29-62)106(169)142(10)81(25-18-45-125-110(120)121)99(162)136-78(52-65-54-122-56-126-65)94(157)135-77(51-64-32-38-68(149)39-33-64)97(160)139-86(58(6)12-2)102(165)137-79(53-85(114)151)95(158)134-76(48-57(4)5)96(159)140-87(59(7)13-3)103(166)141-88(61(9)146)104(167)130-71(24-17-44-124-109(118)119)91(154)129-72(40-41-84(113)150)93(156)128-70(23-16-43-123-108(116)117)92(155)133-75(89(115)152)50-63-30-36-67(148)37-31-63/h28-39,54,56-61,69-83,86-88,145-149H,11-27,40-53,55,111-112H2,1-10H3,(H2,113,150)(H2,114,151)(H2,115,152)(H,122,126)(H,127,163)(H,128,156)(H,129,154)(H,130,167)(H,131,153)(H,132,161)(H,133,155)(H,134,158)(H,135,157)(H,136,162)(H,137,165)(H,138,164)(H,139,160)(H,140,159)(H,141,166)(H4,116,117,123)(H4,118,119,124)(H4,120,121,125)/t58-,59-,60-,61+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,86-,87-,88-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	>1.00E+3	n/a	n/a	n/a	n/a	n/a
Salk Institute Curated by ChEMBL					Assay Description Displacement of l25I-PYY from Neuropeptide Y receptor type 1 of human neuroblastoma SK-N-MC cells				J Med Chem 35: 3653-9 (1992) BindingDB Entry DOI: 10.7270/Q2QZ2BK9
					More data for this Ligand-Target Pair